Tendon-lengthening surgery versus botulinum toxin injections for hand and wrist spasticity
Official title: The Effectiveness of Spasticity-correcting Upper Limb Surgery Versus Botulinum Toxin Injections in Patients With Upper Limb Spasticity: an Experimental Study With Paired Design
Run by Vastra Gotaland Region · NCT06733025 · Data updated 2026-11-12
This project tries to see if tendon-lengthening surgery helps adults with hand and wrist spasticity after stroke, spinal cord injury, or traumatic brain injury more than ongoing botulinum toxin injections.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 30 (estimated) |
| Sponsor | Vastra Gotaland Region Government |
| Locations | 1 site (Mölndal) |
| Status | Recruiting |
| Started | January 7, 2025 |
| Main results expected | January 29, 2029 |
| Study ends | June 29, 2029 |
| Registry record updated | September 17, 2025 |
| Trial ID | NCT06733025 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Adults (18+) with problematic upper-limb spasticity after stroke, TBI, or spinal cord injury who have been on BoNT treatment for the hand/wrist, are at least six months post-injury, and are medically stable for surgery are ideal candidates.
✕Probably not a fit
Patients with recent injury under six months, fewer than two affected hand/wrist muscles, major concurrent upper-limb injuries, or who are not medically fit for surgery may not benefit from or be eligible for the surgical arm.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This open-label, non-randomized paired-design study at Sahlgrenska University Hospital compares tendon lengthening surgery to ongoing botulinum toxin (BoNT) injections for upper-limb spasticity affecting hand and wrist function. Eligible adults are at least six months post-injury (stroke, TBI, or SCI), currently receiving BoNT with at least three months since their last injection, and have at least two hand/wrist muscles considered for treatment. Participants either undergo tendon-lengthening surgery with standard postoperative care or continue BoNT injections combined with community therapy, and outcomes focus on hand function, activities of daily living, and longer-term spasticity control. The team uses a stratified surgical algorithm based on residual motor function and follows patients over time to compare durable functional benefits.
Why it matters
Potential benefit: If successful, surgery could provide longer-lasting improvement in hand function and independence compared with repeated BoNT injections.
How similar studies have gone: Surgical approaches for focal upper-limb spasticity have shown promising long-term results in case series, but there are few high-quality comparative trials directly contrasting surgery with BoNT.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: 1. 18 years or above 2. Problematic spasticity, characterised by a velocity-dependent increase in tonic stretch reflexes or intermittent or sustained involuntary muscle activity in the UL after stroke, TBI, or SCI 3. Patients treated at least 6 months after the injury event 4. Ongoing BoNT treatment in the UL 5. A minimum of 3 months passed since the last BoNT injection 6. At least two muscles in the hand and wrist were considered for treatment 7. For the BoNT group, a community occupational or physical therapist was assigned for post BoNT treatment 8. For the surgery group, medically stable to undergo surgery 9. No other severe UL injuries affecting the functional level Exclusion Criteria: \-
Where it's running
-
Sahlgrenska University Hoispital
Mölndal, Sweden Recruiting
Study contacts
- Study coordinator: Therese Ramström, PhD
- Email: therese.ramstrom@vgregion.se
- Phone: +46(0)761357416
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
How VR Can Make a Virtual Body Feel Real
This study tests different immersive virtual reality techniques to see which best makes a person feel the virtual body as their own, including in people with spinal cord injury or stroke.
-
Gait and Achilles Tendon Properties in Spastic Paresis
This study tests how the Achilles tendon and calf muscle function during walking in people with spastic weakness after stroke or spinal cord injury, compared with healthy individuals.
-
Spatial StimelMD for upper-limb recovery after stroke or traumatic brain injury
This trial will test whether adding the Spatial StimelMD device to standard rehabilitation helps adults with upper-limb weakness after stroke or traumatic brain injury improve arm movement.
-
Combining non-invasive brain and spinal cord stimulation to improve arm and hand function
This study tests whether pairing non-invasive brain stimulation (tDCS) with spinal cord stimulation (tSCS) during a cognitive-motor task can improve sensorimotor and cognitive-motor function in people with cervical spinal cord injury or stroke compared with each stimulation alone or sham.
-
Neuro20 electrical stimulation suit to improve autonomic control, muscle performance, and walking after amputation or neurologic injury
This will test whether wearing the Neuro20 electrical stimulation suit helps people at least one week after an amputation or neurologic injury (stroke, spinal cord injury, or brain injury) improve autonomic function, muscle strength, and walking.
-
Targeting the plantaris tendon during surgery to correct ankle equinus in children
This trial tests whether cutting the small plantaris tendon, together with standard calf-lengthening surgery, helps children aged 4–17 with ankle equinus walk and use their feet better.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.